Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - European Respiratory Review, 2019 - Eur Respiratory Soc
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
[PDF][PDF] Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - 2019 - scholar.archive.org
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
[PDF][PDF] Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - 2019 - scienceopen.com
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - European Respiratory Review, 2019 - cir.nii.ac.jp
抄録< jats: p> Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - … review: an official journal of the …, 2019 - pubmed.ncbi.nlm.nih.gov
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
[HTML][HTML] Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - European Respiratory Review, 2019 - ncbi.nlm.nih.gov
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
[PDF][PDF] Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - 2019 - academia.edu
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.
BF Collins, G Raghu - … Respiratory Review: an Official Journal of the …, 2019 - europepmc.org
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.
BF Collins, G Raghu - European Respiratory Review, 2019 - search.ebscohost.com
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
[HTML][HTML] Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
BF Collins, G Raghu - European Respiratory Review, 2019 - Eur Respiratory Soc
Two antifibrotic medications (nintedanib and pirfenidone) were recommended
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …
(conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the …